About Title21

Founded in 2001, Title21 is a healthcare software company dedicated to digitizing complex, highly regulated workflows in cell and gene therapy (CGT) and advanced therapies. Its platforms replace manual, paper-based processes with integrated digital solutions spanning manufacturing, quality, compliance, and patient delivery. Since 2022, Title21 is backed by ARCHIMED.

The Context

As part of its European expansion, Title21 has acquired MyCellHub, a Belgium-based SaaS company serving biotech and CGT players operating under GMP and GxP constraints. Belgium is now Title21’s European operational hub.

To support this ambition, we are hiring a Vice President Sales Europe & Middle East to own regional commercial growth and build a scalable, high-performing sales organization.

This is a hands-on builder role combining strategy, execution, and leadership in a complex, regulated SaaS environment.

The Role

Reporting to the Chief Co...